Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. The upper and lower pennant lines will intersect in three months. Charts. $0. Created with Sketch. 1. Created with Sketch. 57. 5. caBC OnLine Partnership Office E161, 4000 Seymour Place PO Box 9412, Stn Prov Govt Victoria, BC V8W 9V1Share. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Latest Posts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Hope that SPL starts to deliver on its promises. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. Talk with one of our capital. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. ASX - Day TradingLet's face it SPL is a very small investment for most of the institutions, they work on the basis of having a portfolio of these "penny dreadfuls" and expect some to come good but most to fail. Charts. StarPharma Holdings Ltd. Created with Sketch. There appears to be a different behavioural feel about. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ASX - By Stock. Since September 2020 the. 59pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. ASX - Day TradingIn my opinion, most rational people would have to concede/agree that Starpharma’s three SPL7013 commercialised products (Fleurstat, condoms and Viraleze) have been commercial flops so far. Build your trading strategy and connect with. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Advertise on HotCopper. ASX - By Stock. ASX - Day TradingSPL buy back distribution agreement , LLoyds hand it back or SPL formally takes action for the agreement to be cancelled due to a default in obligations. Some years ago SPL failed an FDA trial for the same product when Jackie was CEO. . More. I no longer regard SPL as an investment-grade stock. I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. The thread is titled so that it can be found and general enough so as to. 4¢. Click for. When it goes to 62 cents, and it will as it's 1 cent away, it will be a 282-week low, or 5 years 8 months since it's been at that level, that's a lot of holders if not all on them in the red. . Target our investor community with our. 616553. Application for quotation of securities - SPL. Target our investor community with our suite of. Last updated 10. Market . ASX - Short Term Trading. Volume. It is a real eye opener and paints the Pharmaceutical Industry in a very bad light. SPL. . There is potentially a multi-bagger upside if there was an exceptionally good news announcement. In SPL's case there is clearly another. Share In the last year we have seen the resignation of the Head of Research, David Owen and now the Chief Financial Officer, Nigel Baade. HotCopper is Australia's largest free and independent stock market trading forum for. Created with Sketch. A new DFS upgrade has expanded operation capacity on-site the project from 15 gigawatt hour’s worth of battery production to 120GWh. So the Scripps evidence of efficacy will be the main basis for the decision. 6 MILLION HY LOSS FROM CONTINUING OPERATIONS. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. Merck -- 2. Forums. $0. Created with Sketch. 22/9/2000 CSL $11. There is potentially a multi-bagger upside if there was an exceptionally good news announcement. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. Last post JoeSalami. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. Each to their own. ”For your information 55% of the company is held by institutions” ~ AB I. ROFL. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Charts. ASX - Day TradingSo the share price of SPL rose up to a high of $2. ASX - General. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. LEADING THE BATTERY METALS REVOLUTION. Since then. 30. ” This, sadly, is not true. Market Cap $55. 5¢. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Last updated 15. Join the HotCopper ASX share market forum today for free. 5,006,219 was the total short sales as of 21/07/23 (1. Contacts. Latest Posts. 48. Time flies. 00% 14. 0. The matter has been adjourned to. DISCOVER THE BATTERY METALS REVOLUTION. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. Created with Sketch. Hey, "smart", I concur with your message. Notification of cessation of securities - SPL. Check out the spin on this promo---One ASX company Set to Revolutionise the $112 BILLION Cancer-Drug MarketBy: Adam SurpliceIndustry experts expect that. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Last edited by antibotter : 13/11/23. Last updated 15. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Last post 1stPrize. And that is my opinion too but about SPL. 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. Market . Created with Sketch. ASX - By Stock. Created with Sketch. . J K Fairley $1,272,084N J Baade. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. SPL scientists will no doubt be working on this right now. Created with Sketch. 0¢. Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. ASX - By Stock. ASX - By Stock. 375) mark and followed up with a roughly 23. most else of the list is same as we want to happen years ago and long long overdue. 375% 0. 362771. Share Financial Analysis: "Dr Jackie Fairley, CEO, Starpharma, commented:These very positive results for DEP® cabazitaxel in three common and hard-to-treat cancers demonstrate its therapeutic and commercial value" The phase 2 results look great and certainly demonstrate therapeutic value. 0. Commodities. 56% 14. Market . ASX - By Stock. Hey, "smart", I concur with your message. Today it closes up 5% on the high of the bar and all we here. SPL Price at posting: 44. Along with SPL's seemingly better ADC compared to AZ's Enhertu, perhaps Pascal Soriot is wondering if he jumped into bed with the the wrong partner in Daiichi-Sankyo. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. StarPharma Holdings Ltd. Volume. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 0. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. ASX - Short Term Trading. 0000. Created with Sketch. Created with Sketch. I recommend that everyone sees the below. I hope I'm wrong here. ASX - General. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. Join the HotCopper ASX share market forum today for free. Created with Sketch. 6% downward extention down to (0. Forums. Click for more information. 06 Sentiment: Buy Disclosure: Held Created with Sketch. . 70% 14. 367026. Yes I think SPL does have a future but TIME is of the essence. Join the HotCopper ASX share market forum today for free. NEW YORK TRANSN DEV CORP SPL FAC REV 4. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - Day Trading. Latest Posts. As always, she is happy to hoover up freebie shares in the grandiose remuneration agreements as well as collect performance bonuses as disclosed in the Annual Report. 5¢. 37pm 10/11/2023 ? HotCopper has news, discussion, prices and market data on WHISPIR LIMITED. 8¢. If SPL come out with more data and partners or a potential pathway to sales, great, i will change my view and the price will likely spike. municipal. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Unusual to make that announcement?. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. m. The digital display offers a 0. Created with Sketch. Latest Posts. Target our investor community with our suite of Hotcopper Advertising. 7¢. 03% or subsequently a decrease in shorts of. 5 cents. . Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. But SPL is different, isn't it? SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. bc. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. Join the HotCopper ASX share market forum today for free. Created with Sketch. municipal. Join the HotCopper ASX share market forum today for free. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. . SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). 75. Market Cap $58. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. . NSX - By Stock. ASX - Day Trading. AB you'd better start going out on Friday nights and liveing it up to get in practice for the celebrations when SPL hits the big time! SPL Price at posting: $1. Market . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Market Cap $. Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. 607432. 0. 5 years Starpharma has not publicly released any information to the ASX about progress of the partnership. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. . ASX - By Stock. Within a post on another SPL thread, sarge17 said: "I wonder what polished horse turd of an announcement we will get from Starpharma in the final days leading up to the AGM. Taking Cols scenario for a sting like buyout if the buyout price is higher than the highest price the company has reached there is no avenue for complaint. opportunities galore IMO but we are likely to miss the boat again based on past performance of JF & Co. That's how markets work sometimes. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . We know that they haven't been marketed well but i think BigPharma have had an input. , page-2. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. ASX - By Stock. Some days I wondered if I'd see 91c again, but when the Vivagel phase 3 announcement came out I loaded up big time. “It wouldn't surprise me if Starpharma have and are talking with big pharma in a joint collaboration to further develop SPL7013 for other. Follow your favourite stocks, view charts, track. Forex. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. my apologies that I could not stay after the. Advertise on HotCopper. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. That won’t be a shock to. (OTCQX: SPHRY | ASX: SPL) Thursday, June 25, 2020 12:00 p. The borders are now open Look forward to a positive outcome with new partnership agreements permeating from our team networking at ASCO. Enquire Now & Supercharge Your Brand with HotCopper 17 Oct 2023. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. 5. Join the HotCopper ASX share market forum today for free. This is a charting thread for those interested in the movements of the SPL SP. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. Last updated 15. ASX - General. Some links within this article worth a scan too. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . An expat Indonesian friend did have search for me but didn't find any promotion etc a little while ago. All ETFs by Morningstar Ratings Morningstar Medalist Rating Gold. 2663916. My last 350 posts take me back over two years and cover about twenty different stocks. 00 and $5. And he still is Chairman or Director of SIX other companies. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. HotCopper is an Australian stock market online chat forum that allows its users to discuss financial topics. Join the HotCopper ASX share market forum today for free. I should declare that I am. ASX - General. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. ASX - Day TradingShare Can you point out what you believe are their failings with respect to regulatory filings for a "medical device"? Also do you consider that government and regulatory sentiment may have had an impact on consumer demand and any advertising plan - its clear that Governments are still fixated on Vaccination to the disregard of any. 5¢. Latest Posts. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. 0¢. New Zealand Dollar. Enter the title of your abstract. Forums. ASX - By Stock. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Created with Sketch. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. Last updated 15. Attached link highlights some of the complexities involved more broadly. SPL - still awaiting human trials!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share New future tech coming Antibody fragment-nanoparticle therapeutic eradicates cancerPosted YesterdayA multi-institutional team of researchers found novel cancer therapeutic, combining antibody fragments with molecularly engineered nanoparticles, permanently eradicating gastric cancer in treated mice. 11%. 70 Sentiment: Sell Disclosure: Held Not only did AZ not announce completion of Phase 1 with stellar results, the commencement of Phase 2 and a big milestone payment to SPL as the pompom brigade were postulating, it was just interim Phase 1 results and dose escalation apparently continues. ASX - Short Term Trading. In SPL's case there is clearly another. 6. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. ASX - General. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Notice to Sellers of Vapour Products – PST Rate Increase to 20% Page 3 of 3 Need more info? Online: gov. Disowned him really. In summary, my observations about SPL are: Marketing - persistent. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. IMO maybe you positive posters should just take a breather for a little while and wait until the tide turns and this company shows some signs of life?Sept 28 (Reuters) - Starpharma Holdings Ltd (SPL) : REQUESTS FOR A TRADING HALT PENDING AN ANNOUNCEMENT TO MARKET REGARDING A PROPOSED EQUITY CAPITAL. 83453. 26. are either confused or talking nonsense. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. Antibotter despite you starting 23 separate Starpharma threads in 3 weeks you do not own this Hotcopper forum. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. comImagine what SPL's newflow and updates would look like without Viraleze. 0¢. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. - 12:30 p. . SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". 50 or. The AGM has come and gone What did we learn from this meeting according to our attendee's who post on HotCopper forum When it comes to. Hey, "smart", I concur with your message. Energy. Created with Sketch. On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. 16,364,160. . As we know from the latest SPL update, it’s still ongoing… In my opinion, she is the WORST value CEO on the ASX. 26. LEADING THE BATTERY METALS REVOLUTION. $-0. , page-4. 06B ! Add to my watchlist. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. 0¢. . Created with Sketch. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. Created with Sketch. New Zealand Dollar. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Virtual investor presentation Tomorrow night Starpharma will be Participating in a virtual investorpresentation on the OTC website for those that are. Market . Forums. SUBMISSION STEPS. Latest Posts. When a board member uses rheir own hard earned cash and buys $350,000 worth of shares. ASX - General. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. I was hoping for. , page-3. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. 166028. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 1541401. Working in a. I've been a SPL shareholder since Nov 2015 when I bought a small parcel at 91c. 1dB. 00%. ASX - By Stock. 25. Over the 3 year period the index has remained at around 40,000 whereas the SPL SP has dropped around 70%. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based.